Corcept Therapeutics | CORT - Bienes





Bienes Cambio Fecha
Acadia Pharmaceuticals USD 1.61B 41.04M 2026-03
Alaunos Therapeutics USD 1.88M 1.08M 2026-03
ANI Pharmaceuticals USD 1.42B 18.41M 2026-03
Ardelyx USD 504.51M 2.9M 2026-03
Assertio Holdings USD 319.77M 46M 2025-09
Aurora Cannabis CAD 775.29M 18.43M 2025-12
BioMarin Pharmaceutical USD 8.59B 996.99M 2026-03
Bristol-Myers Squibb USD 86.48B 3.56B 2026-03
Canopy Growth CAD 1.11B 36.35M 2025-12
Corcept Therapeutics USD 814.88M 21.77M 2026-03
Eli Lilly USD 116.58B 4.1B 2026-03
Esperion Therapeutics USD 462.53M 3.36M 2026-03
J&J USD 200.89B 1.68B 2026-03
Knight Therapeutics CAD 1.05B 2.28M 2025-12
Lexicon Pharmaceuticals USD 268.82M 83.83M 2026-03
Merck USD 128.68B 8.18B 2026-03
Nektar Therapeutics USD 280.41M 20.94M 2025-12
Novartis USD 118.53B 7.58B 2026-03
Novartis USD 110.95B 3.66B 2025-12
Omeros USD 200.57M 34.59M 2025-06
Pacira USD 1.21B 56.38M 2026-03
Pfizer USD 207.62B 542M 2026-03
Supernus Pharmaceuticals USD 1.5B 48.08M 2026-03
TG Therapeutics USD 1.53B 465.58M 2026-03